Description: Recently, life insurers have seen a lot of change in their business model. Whether it be new accounting rules (e.g., long-duration targeted improvements [LDTI]) or new capital charges (e.g., structured equity tranche), companies are being forced to reconsider how they invest their assets. Today's session will help attendees understand how companies are using modelling software to help understand the impact of these changes on both their existing portfolio and potential changes that these new regulations may lead to. By attending, attendees will get a better understanding of: - How life insurers' asset allocation decisions are different than other financial companies (e.g., banks, pension funds, P&C companies) - How these changes may impact the risk vs. reward tradeoffs that life insurers' face - How these companies can use modelling software to help evaluate these potential impacts

Description: This session reviews the importance of using benchmarks in healthcare utilization management to improve organizational and patient outcomes and increase efficiency. It highlights how benchmarks can inform decisions about utilization management strategies and benefit members, payers, and providers. The presentation includes best practices, successful examples, and solutions to challenges, focusing on claim utilization, risk adjustment efficiency, quality metrics, and overall performance. Additionally, insights into the future of benchmarks and the value of analyzing the entire distribution of data for deeper insights will be shared.

Description: Presenters will discuss difficulties within the new NAIC ESG, such as how the model deals with interest rate flooring and its treatment of the linkage between equity and treasury bond returns. They will also discuss the documentation and governance process surrounding the new NAIC ESG.

Description: In 2006, a pioneering research paper was published on practical considerations for Economic Capital (EC), which has remained a staple on the Society of Actuaries (SOA) exam syllabus ever since. For many, that time represented the golden era of EC-often dubbed the œquantification of Enterprise Risk Management with nearly every major U.S. life insurer performing some form of EC calculation. However, following the 2008-2009 financial crisis, EC fell into disfavor in some circles. Several companies that appeared healthy from an EC perspective prior to the crisis were found to be far more vulnerable afterward.

Description: Diane Swonk, Economist, KPMG, Currently the chief economist for global auditing firm KPMG, Diane Swonk has more than 30 years of experience in financial services and sits on advisory committees to the Federal Reserve Board and its regional banks. She is currently on the U.S. Chamber of Commerce economic advisory board.

Description: Session 6H: Analyzing Healthcare Costs by Disease - Commercial versus Medicare Trends

Description: Session 4F: Clear as Mud - The Impact of Price Transparency

Description: Cost is a key outcome metric used by actuaries and others to determine the value of a benefit or program in health insurance. However, typically, costs assessed include only the direct costs of the program, not any indirect costs or savings, such as those associated with reduced spending on other services.

Description: When designing and pricing a healthcare product, it is not only important to know how to model frequency and severity, but it is essential to understand human behavior. Of course, the issue of anti-selection in medical insurance is well known as individuals know more about their health and prior expenditures than an insurer does. This type of behavior is certainly rational, and to be expected.

Description: This article gives you a different way to think about economics from a system science perspective and introduces concepts such as complexity, emergence, and interdependence. The concepts allow better conformity to the behavior of the markets and policyholder behavior.